Medical News Today: Breast cancer: Study identifies a molecular mechanism of drug resistance in ER+ tumors

Study suggests that a mechanism of drug resistance in ER+ breast cancers could be changes to the estrogen receptor caused by two immune system molecules. Medical News Today: Breast cancer: Study identifies a molecular mechanism of drug resistance in ER+ tumors